Not available
Quote | Agenus Inc. (NASDAQ:AGEN)
Last: | $6.56 |
---|---|
Change Percent: | -0.75% |
Open: | $6.01 |
Close: | $6.56 |
High: | $6.65 |
Low: | $5.99 |
Volume: | 758,943 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Agenus Inc. (NASDAQ:AGEN)
2024-07-26 14:22:18 ET Summary We share 12 ideas published last week focused on stocks with less coverage on Seeking Alpha. Despite the decline in stock price for small biotech Agenus, one analyst thinks it could have further to go. Lithium Americas Corp. could be positioned f...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its second quarter 2024 financial results before the market opens on Thursday, August 8, 2024. Agenus executives will host a co...
Message Board Posts | Agenus Inc. (NASDAQ:AGEN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $AGEN News Article - Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI | whytestocks | investorshangout | 05/03/2023 6:35:51 PM |
shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma | shalbyj | investorshangout | 04/25/2023 1:37:15 PM |
whytestocks: $AGEN News Article - Agenus Receives Fast Track Designation for Botensilimab and Balsti | whytestocks | investorshangout | 04/17/2023 12:00:59 PM |
whytestocks: $AGEN News Article - Agenus' Botensilimab in Combination with Balstilimab Shows 33% Dur | whytestocks | investorshangout | 03/27/2023 3:10:50 PM |
whytestocks: $AGEN News Article - Best Penny Stocks To Buy Now: 3 To Watch Before Next Week | whytestocks | investorshangout | 03/15/2023 8:20:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its second quarter 2024 financial results before the market opens on Thursday, August 8, 2024. Agenus executives will host a co...
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agenus Inc. ("Agenus" or "the Company") (NASDAQ:AGEN). Investors who purchased Agenus securities are encouraged to obtain additional information and ass...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agenus Inc. ("Agenus" or "the Company") (NASDAQ:AGEN). Investors who purchased Agenus securities are encouraged to obtain additional information and ass...